Effects of soy bean on serum paraoxonase 1 activity and lipoproteins in hyperlipidemic postmenopausal women

International Journal of Food Sciences and Nutrition

Volumn 60, Issue 3, 2009, Pages 195-205

  Shidfar, Farzad ^a   Ehramphosh, Elham ^a   Heydari, Iraj ^b   Haghighi, Ladan ^b   Hosseini, Sharieh ^c   Shidfar, Shahrzad ^d  

^a IRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b IRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c ISLAMIC AZAD UNIVERSITY   (Iran)

^d UMASS MEMORIAL MEDICAL CENTER   (United States)

Author keywords

Lipoprotein' paraoxonase 1; Postmenopausal women; Soy proteins

Indexed keywords

ARYLDIALKYLPHOSPHATASE 1; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; ISOFLAVONE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PLACEBO; SOYBEAN PROTEIN;

AGED; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL METABOLISM; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET SUPPLEMENTATION; DOUBLE BLIND PROCEDURE; ENZYME ACTIVATION; ENZYME BLOOD LEVEL; FEMALE; HUMAN; HYPERCHOLESTEROLEMIA; HYPERLIPIDEMIA; POSTMENOPAUSE; RANDOMIZED CONTROLLED TRIAL; RISK REDUCTION; SOYBEAN;

ARYLDIALKYLPHOSPHATASE; CARDIOVASCULAR DISEASES; CHOLESTEROL, HDL; DOUBLE-BLIND METHOD; FEMALE; HUMANS; HYPERCHOLESTEROLEMIA; IRAN; LIPOPROTEINS; MIDDLE AGED; POSTMENOPAUSE; RISK FACTORS; SOYBEAN PROTEINS; TIME FACTORS;

EID: 68349150630     PISSN: 09637486     EISSN: 14653478     Source Type: Journal    
DOI: 10.1080/09637480701669463     Document Type: Article

References (42)

1. Anderson JW. 2003. Diet first, then medication for hypercholesterolemia. JAMA 290:531-533.
2. Anderson JW, Johnstone BM, Cook-Newell ME. 1995. Meta-analysis of the effects of soy protein intake on serum lipids. N Engl J Med 333:276-282.
3. Aviram M, Rosenblat M, Bisgaier CL, Newton RS, Primo-Parmo SL. 1998. Paraoxonase inhibits highdensity lipoprotein oxidation and preserves its function. A possible peroxidative role for paraoxonase. J Clin Invest 101:1581-1590.
4. Baum JA, Teng H, Erdman JW. 1998. Long-term intake of soy protein improves blood lipid profiles and increases mononuclear cell LDL receptor messenger RNA in hypercholesterolemic, postmenopausal women. Am J Clin Nutr 68:545-551.
5. Bhathena SJ, Velasquez MT. 2002. Benefical role of dietary phytoestrogens in obesity and diabetes. Am J Clin Nutr 76:1191-1201.
6. Bush NJ, Griffin-Sobel JP. 2003. Hormone replacement therapy in postmenopausal women. Oncol Nurs Forum 30:747-749.
7. Chiechi LM, Secreto G, Vimercati A, Greco P, Venturelli E. 2002. The effects of soy rich diet on serum lipids: The Menfis randomized trial. Maturitas 41:97-104.
8. Craig CL, Marshall AL, Sjostrom M, Bauman AE, Booth ML. 2003. International physical activity questionnaire: 12-country reliability and validity. Med Sci Sport Exerc 35:1381-1395.
9. Dalias FS, Ebeling PR, Kotsopoulos D, McGrath BP, Teed HJ. 2003. The effects of soy protein containing isofalvones on lipids and indices of bone resorption in postmenopausal women. Clin Endocrinol 58:704-709.
10. Dent SB, Peterson CT, Brace LD, Swain JH, Reddy MB. 2001. Soy protein intake by perimenopausal women does not affect circulating lipids and lipoproteins or coagulation and fibrinolytic factors. J Nutr 131:2280-2287.
11. Duffy R, Wiseman H, File SE. 2003. Improved cognitive function in postmenopausal women after 12 weeks of consumption of a soya extract containing isoflavones. Pharmacol Biochem Behav 75:721-729.
12. Engelman HM, Alekel DL, Hanson LN, Kanthasamy AG, Reddy MB. 2005. Blood lipid and oxidative stress responses to soy protein with isoflavones and phytic acid in postmenopausal women. Am J Clin Nutr 81:590-596.
13. Fuhrman B, Volkova N, Aviram M. 2006. Postprandial serum triacylglycerols and oxidative stress in mice after consumption of fish oil, soy oil or olive oil: Possible role for paraoxonase-1 triacylglycerol lipase-like activity. Nutrition 22:922-930.
14. Gan KN, Smolen A, Eckerson HW. 1991. Purification of human serum paraoxonase/arylesterase. Drug Metab Dispos 19:100-106.
15. Goodman Gruem D, Kritz-Silverstein D. 2001. Usual dietary isoflavone intake is associated with cardiovascular disease risk factors in postmenopausal women. J Nutr 131:1202-1206.
16. Hermansen K, Dinesen B, Hoie LH, Morgenstern E. 2003. Effects of soy and other natural products on LDL:HDL ratio and other lipid parameters: A literature review. Adv Ther 20:50-78.
17. Hermansen K, Sondergaard M, Hoie L, Carstensen M. 2001. Benefical effects of a soy-based dietary supplement on lipid levels and cardiovascular risk markers in type 2 diabetic subjects. Diabetes Care 24:228-233.
18. Himbergen TMV, Van Tits LJH, Roest Stalenhoef AFH. 2006. The story of PON1: How an oranophosphate hydrolysing enzyme is becoming a player in cardiovascular medicine. Netherlands J Med 64: 34-36.
19. Hodgson JM, Puddey IB, Beilin LJ, Mori TA. 1998. Supplementation with isoflavonoid phytoestrogens does not alter serum lipid concentration: A randomized controlled trial in Humans. J Nutr 128:728-732.
20. Jayagopal V, Albertazzi P, Kilpatrick ES, Howarth EM, Jennings PE. 2002. Benefical effects of soy phytoestrogen intake in postmenopausal women with type 2 diabetes. Diabetes Care 25:1709-1714.
21. Jenkins DJA, Kendall CWC, Jackson CJA, Connelly PW. 2002. Effects of high- and low-isoflavone soy foods on blood lipids, oxidized LDL, homocysteine blood pressure in hyperlipidemic men and women. Am J Clin Nutr 76:365-372.
22. Jonnalegadda SS, Diwan S. 2002. Nutrient intake of first generation Gujarati Asian Indian immigrants in the U.S. J Am Coll Nutr 21:372-380.
23. Kwon DY, Jang JS, Hong SM, Lee JE, Sung SR. 2007. Long-term consumption of fermented soybean-derived chungkookjang enhances insulinotropic action unlike soybeans in 90% pancreatectomized diabetic rat. Eur J Nutr 46:44-52.
24. Mori TA, Burke V, Puddey IB, Watts GF, Oneal DN. 2000. Purified EPA and DHA have differential effects on serum lipids and lipoproteins, LDL particle size, glucose and insulin in midly hyperlipidemic men. Am J Clin Nutr 71:1085-1094.
25. Nestel P, Yamashita T, Sasahara T, Pomeroy S, Dart A. 1997. Soy isoflavones improve systemic arterial compliance but not plasma lipids in menopausal and perimemopausal women. Arterioscler Thromb Vasc Biol 17:3392-3398.
26. Oh Hy, Kim SS, Chung HY, Yoon S. 2002. Isoflavone supplements exert hormonal and antioxidant effects in postmenopausal Korean women with diabetic retinopathy. J Med Food 8:1-7.
27. Puska P, Korpelainen V, Hoie LH, Skovlund E, Smerud K. 2004. Isolated soya protein with standard levels of isoflavones, cotyledon soya fibres and soya phospholipids improves plasma lipids in hypercholester-olaemia: A double blind, placebo-controlled trial of a yoghurt formulations. Br J Nutr 91:393-401.
28. Rosell MS, Appleby PN, Spencer EA, Key TJ. 2004. Soy intake and blood cholesterol concentrations: A cross-sectional study of 1033 pre-and postmenopausal women in the Oxford arm of the European Prospective Investigation into Cancer and Nutrition. Am J Clin Nutr 80:1391-1396.
29. Rossouw GE, Anderson GL, Prentice RL. 2002. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: Principal results from the women's Health Initiative randomized controlled trial. JAMA 288:321-333.
30. Sacks FM, Lichtenstein A, VanHorn L, Harris W, Kris-Etherton P. 2006. Soy protein, isoflawones, and cardiovascular health; An American Heart Association Science Advisory for professionals from the Nutrition Committee. Circulation 113:1034-1044.
31. Stark KD, Holub BJ. 2004. Differential eicosapentaenoic acid elevations and altered cardiovascular disease risk factor responses after supplementation with docosahexaenoic acid in postmenopausal women receiving and not receiving hormone replacement therapy. Am J Clin Nutr 79:765-773.
32. Sutherland WHF, Manning PJ, Dejong SA, Allum AR, Jones SD. 2001. Hormone-replacement therapy increases serum paraoxonase arylesterase activity in diabetic postmenopausal women. Metabolism 50:319-324.
33. Teede HJ, Dalais FS, Kotsopulos D, Liang Y-L, Davis S. 2001. Dietary soy has both benefical and potentially adverse cardiovascular effects: A placebo-controlled study in men and postmenopausal women. J Clin Endocrinol Metab 86:3053-3060.
34. Teede HJ, McGrath BP, Desilva L, Cehum M, Fassoulakis A. 2003. Isoflavones reduce arterial stiffness: A placebo-controlled study in men and postmenopausal women. Arterioscler Thromb Vasc Biol 23:1066-1071.
35. Tonstad S, Smerud K, Hoie L. 2002. A comparison of the effects of 2 doses of soy protein or casein on serum lipids, serum lipoproteins and plasma total homocysteine in hypercholesterolemic subjects. Am J Clin Nutr 76:78-84.
36. Tsygnova TB, Klassina SIA, Konotop NS. 2001. Soya protein-lipid complex as a corrective agent of lipid metabolism and functional state in moderate hypercholesterolemia. Vopr Pitan 70:25-28.
37. Vincent A, Fitzpatrick LA. 2000. Soy isoflavones: Are they useful in menopause? Mayo Clin Proc 75:1174-1184.
38. Wangen KE, Duncan AM, Xu X, Kurzer MS. 2001. Soy isoflavones improve plasma lipids in normocholesterolemic and mildly hypercholesterolemic postmenopausal women. Am J Clin Nutr 73:225-231.
39. Wanger JD, Schwenke DC, Greaves KA, Zhang L, Anthony MS. 2003. Soy protein with isoflavones, but not an isoflavone-rich supplement improves arterial low-density lipoprotein metabolism and atherogensis. Arterioscler Thromb Vasc Biol 23:2241-2246.
40. West SG, Hipert KF, Juturu V, Bordi PL, Lampe JW. 2005. Effects of including soy protein in a blood cholesterol-lowering diet on markers of cardiac risk in men and in postmenopausal women with and without hormone replacement therapy. J Womens Health 14:253-262.
41. Yaman T, Matsumoto T, Nakae I, Takashima H, Tarutani Y. 2006. Impact of paraoxonase polymorphism (Q 192R) on endothelial function in intact coronary circulation. Hypertens Res 29:417-422.
42. Zhang X, Shu XO, Gao YT, Yang G, Li Q, Li H. 2003. Soy food consumption is associated with lower risk of coronary heart disease in Chinese women. J Nutr 133:2874-2878.